Table 2.
Information of Samples Who Were Detected with in Resistance Mutations
| Sample ID | Year | Age | Gender | Transmission Route | Subtype | Viral Load | CD4 | Mutation | Level of Drug Resistance | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAB | BIC | DTG | EVG | RAL | |||||||||
| Patient 1 | 2019 | 54 | F | Homosexual | CRF01_AE | 20157 | 133 | E157Q | S | S | S | PL | PL |
| Patient 2 | 2019 | 32 | M | Homosexual | CRF01_AE | 11975 | 346 | E138A | PL | PL | PL | L | L |
| Patient 3 | 2020 | 25 | M | Homosexual | CRF07_BC | 331048 | 280 | T97A | S | S | S | PL | PL |
| Patient 4 | 2020 | 27 | M | Homosexual | B | 147538 | 11 | E157Q | S | S | S | PL | PL |
| Patient 5 | 2021 | 26 | M | Heterosexual | CRF01_AE | 65227 | 261 | Q95K | S | S | S | PL | PL |
| Patient 6 | 2021 | 42 | M | Homosexual | unassigned_1 | 87,194 | 12 | E157Q | S | S | S | PL | PL |
| Patient 7 | 2021 | 52 | M | Homosexual | CRF02_AG | 1334184 | 11 | G163R | S | S | S | L | L |
| Patient 8 | 2021 | 48 | F | Homosexual | CRF01_AE | 14007 | 757 | T97A | S | S | S | PL | PL |
| Patient 9 | 2021 | 19 | M | Homosexual | C | 145444 | 203 | E157Q | S | S | S | PL | PL |
| Patient 10 | 2021 | 38 | M | Homosexual | CRF01_AE | 195967 | 15 | E157Q | S | S | S | PL | PL |
| Patient 11 | 2021 | 31 | M | Homosexual | CRF07_BC | 91862 | 217 | S230R | PL | L | L | L | L |
| Patient 12 | 2021 | 35 | M | Homosexual | CRF01_AE | 47816 | 141 | E157EQ | S | S | S | PL | PL |
Abbreviations: F, Female; M, Male; CAB, Cabotegravir; BIC, Bictegravir; DTG, Dolutegravir; EVG, Elvitegravir; RAL, Raltegravir; S, Susceptible; PL, Potential low-level resistance; L, low-level resistance.